Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

Pfizer (PFE) closed the latest trading day at $25.23, indicating a -1.33% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.82%. Meanwhile, the Dow ...

We recently compiled a list of the 8 Best American Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

Pfizer has had its own issues with falling Covid-19 vaccine sales weighing on its stock performance over the recent years.

Today, Benzinga 's options scanner spotted 29 uncommon options trades for Pfizer. This isn't normal. The overall sentiment of ...

On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $25.57 which represents a decrease of $-0.53 or -2.03% from the prior close of $26.1. The stock opened at $26.1 and touched a low of ...

Health care companies are taking a step back to better understand patients' experiences after a powerful U.S. health ...

The chief medical officer of Amazon.com's pharmacy unit is hopeful that U.S. health secretary nominee Robert F. Kennedy Jr.

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

BofA reinstated coverage of Pfizer (PFE) with a Neutral rating and $29 price target Uncertainty over COVID revenue streams plus a “tough” base ...

Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks offers value investors a ...

Wolfe Research has recently initiated Pfizer Inc (PFE) stock to Underperform rating, as announced on November 15, 2024, according to Finviz. Earlier, on October 25, 2024, Citigroup had resumed the ...